The box office crown is up for grabs this weekend, and a pair of wildly different releases are poised to fight over it. "Street Fighter," a big-budget action-fantasy reimagining of the beloved video game franchise, opened October 13 and is already muscling its way toward the top of the charts. But it faces an unexpected challenger in a buzzy documentary about Elizabeth Holmes, the disgraced Theranos founder, which is tracking for a surprisingly strong debut of its own. Two films, one about warriors trading blows and another about a startup founder trading lies, could end up splitting audiences in ways that make for an unusually tense box office standoff.

A Franchise Reborn With a Director Known for Chaos

"Street Fighter" arrives with considerable heat behind the camera. Kitao Sakurai, best known for his work on the anarchic "Bad Trip" and his collaborations with Eric Andre, directs a script that pulls from deep within the games' lore. The story picks up in 1993, when estranged fighters Ryu and Ken Masters find themselves dragged back into combat by the enigmatic Chun-Li, who recruits them for the next World Warrior Tournament. What begins as a clash of fists and fate quickly curdles into something darker: a deadly conspiracy that forces the two former friends to confront each other and the demons of their past. The marketing has leaned hard into its tagline promise: if they fail, it's game over.

Andrew Koji, who earned acclaim for his work in "Warrior," leads the cast as Ryu, with Noah Centineo stepping into the role of Ken Masters. Callina Liang plays Chun-Li. The supporting roster reads like a genre fan's wish list: David Dastmalchian as the villainous M. Bison, Eric Andre as Don Sauvage, Andrew Schulz as Dan Hibiki, Mel Jarnson as Cammy, and professional wrestler Cody Rhodes as Guile.

At 120 minutes, the film is aiming for the kind of spectacle that fills theaters and sells merchandise. Its current TMDb rating of 6.6 out of 10 suggests audiences are enjoying it without quite calling it a masterpiece, which is often enough for a franchise starter.

The Unexpected Contender: A Holmes Documentary With Heat

While "Street Fighter" was expected to dominate, the documentary about Elizabeth Holmes has emerged as a genuine curiosity. The film examines the rise and fall of the Theranos founder, whose blood-testing company collapsed amid fraud allegations and who became a cultural symbol of Silicon Valley hubris. Early tracking indicates strong interest, particularly among adult audiences who have followed the saga through podcasts, books, and a previous scripted dramatization. That overlap in release timing creates a fascinating split: one film offers escape through fantasy combat, the other delivers a real-life cautionary tale about ambition and deception. Distributors for both titles are likely watching pre-sale numbers closely.

Why This Weekend Matters Beyond the Numbers

For Hollywood, the outcome carries larger implications. "Street Fighter" represents another attempt to convert a beloved game property into a sustainable film series, a task that has confounded studios for decades. Success here could accelerate a wave of similar adaptations. A strong Holmes documentary debut, meanwhile, would reinforce the theatrical appetite for nonfiction crime stories, a genre that has found renewed life on the big screen.

The two films also compete for a shared demographic of younger adults who grew up with the games and who now consume true-crime content voraciously. How that audience splits its dollars over the coming days will tell executives plenty about what draws people out of their homes.

Neither film needs to obliterate the other for the weekend to be considered a win. But the race itself, between a tournament of fists and a founder's downfall, offers a snapshot of what today's moviegoers actually want. For now, "Street Fighter" holds the edge in pre-release awareness. The Holmes doc, though, is quietly landing punches of its own.

Source: Hollywood Reporter